Bioorthogonal Chemical Epigenetic Modifiers Enable Dose-Dependent CRISPR Targeted Gene Activation in Mammalian Cells | ACS Synthetic Biology
![Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020 Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020](https://journals.sagepub.com/cms/10.1177/1078155219895079/asset/images/large/10.1177_1078155219895079-fig1.jpeg)
Driving toward precision medicine for B cell lymphomas: Targeting the molecular pathogenesis at the gene level - Clement Chung, 2020
![Cells | Free Full-Text | Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas Cells | Free Full-Text | Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas](https://www.mdpi.com/cells/cells-10-01533/article_deploy/html/images/cells-10-01533-g001.png)
Cells | Free Full-Text | Fibroblast Growth Factor Receptor (FGFR) Signaling in GIST and Soft Tissue Sarcomas
![MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aan4470/asset/33b79a75-5694-4a27-931b-20f56bccb6fb/assets/graphic/aan4470-f1.jpeg)
MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma | Science Translational Medicine
![Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.1c00136/asset/images/large/jm1c00136_0002.jpeg)
Discovery of STAT3 and Histone Deacetylase (HDAC) Dual-Pathway Inhibitors for the Treatment of Solid Cancer | Journal of Medicinal Chemistry
![Frontiers | Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions Frontiers | Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions](https://www.frontiersin.org/files/Articles/549879/fonc-10-01594-HTML-r1/image_m/fonc-10-01594-t001.jpg)
Frontiers | Chimeric Antigen Receptor T-Cells in B-Acute Lymphoblastic Leukemia: State of the Art and Future Directions
![Frontiers | From Discrete to Continuous Modeling of Lymphocyte Development and Plasticity in Chronic Diseases Frontiers | From Discrete to Continuous Modeling of Lymphocyte Development and Plasticity in Chronic Diseases](https://www.frontiersin.org/files/Articles/442496/fimmu-10-01927-HTML/image_m/fimmu-10-01927-g001.jpg)
Frontiers | From Discrete to Continuous Modeling of Lymphocyte Development and Plasticity in Chronic Diseases
![BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27176-w/MediaObjects/41467_2021_27176_Fig1_HTML.png)
BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma | Nature Communications
![A network of epigenomic and transcriptional cooperation encompassing an epigenomic master regulator in cancer | npj Systems Biology and Applications A network of epigenomic and transcriptional cooperation encompassing an epigenomic master regulator in cancer | npj Systems Biology and Applications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41540-018-0061-4/MediaObjects/41540_2018_61_Fig1_HTML.jpg)